Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer


5th World Congress on Cancer Therapy

Atlanta, USA

Elke Wagler

Department of General, Visceral and Oncosurgery, Pleißental-Klink Werdau, Germany

Title: Cytoreductive surgery and HIPEC for peritoneal carcinomatosis of a gallbladder carcinoma


Biography: Elke Wagler


Introduction: Th e prognosis of gallbladder carcinoma is extremely poor as tumors usually do not show any symptoms until they have become advanced. As a result, in most cases the tumor cannot be removed by surgery completely. Th e fi ve-year survival rate of patients is approximately 6-7%. Aft er diagnosis the median survival time is approximately four to fi ve months. If the carcinoma is removed completely, the fi ve-year survival rate will increase to 10-60%. Methods: One female patient with gallbladder carcinoma who had a primary R1 resection of the gallbladder, partial liver tissue as well as the Whipple procedure, developed a small bowel ileus aft er three months. Th is occured due to a large nodular peritoneal carcinomatosis without evidence of extra peritoneal metastasis. A primary cytoreductive surgery was performed followed by HIPEC. Results: Th e intra- and postoperative progress was uncomplicated with primary wound healing. Th e patient received an additive systematic chemotherapy aft er the completion of her rehabilitation. Th e current staging shows no evidence of recarcinomatosis or metastasis. Conclusion: Th e HIPEC is a modern technique which can be used especially for patients with metastatic cancer. In the current literature there can be hardly found any information on the practice of HIPEC in patients with metastatic gallbladder or bile duct carcinoma. An accurate selection of a potential patient plays a key role.